Establishment Labs Holdings (ESTA) EBT Margin (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly EBT Margin came in at 21.87% in Q1 2026, up 2597.0% year-on-year from 0.81% in Q1 2025, and down 18.59% quarter-over-quarter from 18.44% in Q4 2025.
Establishment Labs Holdings (ESTA) EBT Margin (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' EBT Margin history runs 10 years deep, the most recent figure standing at 21.87% for Q1 2026.
- On a quarterly basis, EBT Margin rose 2597.0% year-over-year to 21.87% in Q1 2026; TTM through Mar 2026 was 22.35%, a 2973.0% increase from a year earlier, with the FY2025 full-year figure at 27.49%, up 2348.0% from the prior year.
- EBT Margin retreated to 21.87% in Q1 2026 per ESTA's latest filing, from 18.44% in the prior quarter.
- Across five years, EBT Margin topped out at 14.39% in Q1 2022 and bottomed at 88.72% in Q2 2022.
- The 5-year median for EBT Margin is 37.97% (2024), against an average of 42.52%.
- Across the five-year window, EBT Margin tumbled 7336 bps in 2022 and jumped 6230 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 29.08% in 2022, then tumbled by 151 bps to 73.03% in 2023, then slipped by 11 bps to 80.74% in 2024, then surged by 77 bps to 18.44% in 2025, then dropped by 19 bps to 21.87% in 2026.
- Per Business Quant, the three latest ESTA EBT Margin figures stand at 21.87% (Q1 2026), 18.44% (Q4 2025), and 19.94% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | -21.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.87% |
| Dec 31, 2025 | -18.44% |
| Sep 30, 2025 | -19.94% |
| Jun 30, 2025 | -30.39% |
| Mar 31, 2025 | -47.84% |
| Dec 31, 2024 | -80.74% |
| Sep 30, 2024 | -40.20% |
| Jun 30, 2024 | -37.97% |
| Mar 31, 2024 | -42.41% |
| Dec 31, 2023 | -73.03% |
| Sep 30, 2023 | -74.28% |
| Jun 30, 2023 | -32.58% |
| Mar 31, 2023 | -23.88% |
| Dec 31, 2022 | -29.08% |
| Sep 30, 2022 | -47.08% |
| Jun 30, 2022 | -88.72% |
| Mar 31, 2022 | -14.39% |
| Dec 31, 2021 | -37.95% |
| Sep 30, 2021 | -50.32% |
| Jun 30, 2021 | -15.36% |